Ab&B Bio Tech Co Ltd JS

Ab&B Bio Tech Co Ltd JS ROE

The Return on Equity (ROE) of Ab&B Bio Tech Co Ltd JS (2627.HK) as of Oct 22, 2026 is -176.49 %. In the previous year, Return on Equity (ROE) was -116.92 % — a change of 50.95% (lower).

ROE

-176.49 %

YoY

50.95%

Last updated:

In 2024, Ab&B Bio Tech Co Ltd JS's return on equity (ROE) was -176.49 %, a 50.95% increase from the -116.92 % ROE in the previous year.

The Ab&B Bio Tech Co Ltd JS ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2023
-116.92 CNY
Jan 1, 2024
-176.49 CNY
The Ab&B Bio Tech Co Ltd JS ROE history
YEARROEYoY
-176.49 %+50.95%
-116.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ab&B Bio Tech Co Ltd JS Stock analysis

What does Ab&B Bio Tech Co Ltd JS do? Ab&B Bio Tech Co Ltd JS generates revenue through the research, development, manufacturing, and commercialization of vaccines. The company's core products include the quadrivalent subunit influenza vaccine and lyophilized human rabies vaccine candidate, alongside 11 other vaccine candidates. It primarily serves the domestic market in China, focusing on vaccine solutions for public health needs. The company's business model centers on bringing its vaccine pipeline to market through domestic sales and commercialization efforts. The firm operates within the biotechnology industry, specifically targeting vaccine development and production. Its product portfolio consists of two core vaccines and 11 additional candidates, all aimed at addressing infectious disease prevention. Ab&B Bio Tech Co Ltd JS leverages its domestic market presence to sell these products, with no mention of international sales or partnerships in the business description. The company's revenue streams derive from the commercialization of its vaccine pipeline, including the quadrivalent subunit influenza vaccine and lyophilized human rabies vaccine candidate. It focuses on the Chinese domestic market for product distribution and sales, with no indication of export activities or foreign market engagement. Ab&B Bio Tech Co Ltd JS's business model emphasizes in-country development and sales of vaccines to meet local healthcare demands. Ab&B Bio Tech Co Ltd JS is one of the most popular companies on Eulerpool.

ROE Details

Decoding Ab&B Bio Tech Co Ltd JS's Return on Equity (ROE)

Ab&B Bio Tech Co Ltd JS's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Ab&B Bio Tech Co Ltd JS's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Ab&B Bio Tech Co Ltd JS's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Ab&B Bio Tech Co Ltd JS’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Ab&B Bio Tech Co Ltd JS stock

Return on Equity (ROE) of Ab&B Bio Tech Co Ltd JS is -176.49 % in 2024.

Return on Equity (ROE) of Ab&B Bio Tech Co Ltd JS changed from -116.92 % to -176.49 %, representing a 50.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Ab&B Bio Tech Co Ltd JS since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Ab&B Bio Tech Co Ltd JS with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Ab&B Bio Tech Co Ltd JS

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Ab&B Bio Tech Co Ltd JS